Skip to main content
Watch Insiders
MGXHealthcare

Metagenomi Inc. (MGX) Insider Trading

In the last 90 days, 4 Metagenomi Inc. (MGX) insiders reported 1 open-market purchase totaling $23,402 and 3 sales totaling $5,107. The most recent open-market purchase was reported on Sep 9, 2026. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$23,402
Corporate buyers
1
Latest transaction
Sep 9, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 9, 2026Laurence ReidDirectorOpen Market Purchase20,000$1.17$23,402
Sep 8, 2026Matthew WeinSee RemarksSale358$1.16$414.71
Sep 8, 2026Jian IrishSee RemarksSale2,140$1.16$2,479
Sep 8, 2026Pamela WapnickChief Financial OfficerSale1,911$1.16$2,214
Jun 5, 2026Pamela WapnickChief Financial OfficerSale2,884$1.30$3,746
Jun 5, 2026Jian IrishSee RemarksSale3,737$1.30$4,854
Jun 5, 2026Matthew WeinSee RemarksSale558$1.30$724.84

Common questions

MGX insider trading FAQ

Are MGX insiders buying or selling?
Over the last 90 days, MGX insiders were net buyers, reporting $23,402 of open-market purchases and $5,107 of sales.
When was the last MGX insider purchase?
The most recent open-market purchase of Metagenomi Inc. stock by an insider was reported on Sep 9, 2026, one of 1 purchase in the last 90 days.
Where does MGX insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Metagenomi Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.